Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data

[1] Hill NR(2016)Global prevalence of chronic kidney disease - a systematic review and meta-analysis PLoS ONE 11 e0158765-2081

[2] Fatoba ST(2010)Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2073-885

[3] Oke JL(2007)Metabolic bone disease in chronic kidney disease J Am Soc Nephrol 18 875-780

[4] Hirst JA(2014)Prevalence of anemia in chronic kidney disease in the United States PLoS ONE 9 e84943-124

[5] O'Callaghan CA(2014)The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov Am J Kidney Dis 63 771-473

[6] Lasserson DS(2016)Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review JAMA Intern Med 176 121-836

[7] Hobbs FD(2021)Incidence of Uncommon Clinical Events in USA patients with dialysis-dependent and nondialysis-dependent chronic kidney disease: analysis of electronic health records from TriNetX Nephron 145 462-254

[8] Matsushita K(2015)Data resource profile: Clinical Practice Research Datalink (CPRD) Int J Epidemiol 44 827-516

[9] van der Velde M(2006)Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med. 145 247-384

[10] Astor BC(2015)The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study BMC Nephrol 16 193-160

[1] Hill NR(2016)Global prevalence of chronic kidney disease - a systematic review and meta-analysis PLoS ONE 11 e0158765-2081

[2] Fatoba ST(2010)Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2073-885

[3] Oke JL(2007)Metabolic bone disease in chronic kidney disease J Am Soc Nephrol 18 875-780

[4] Hirst JA(2014)Prevalence of anemia in chronic kidney disease in the United States PLoS ONE 9 e84943-124

[5] O'Callaghan CA(2014)The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov Am J Kidney Dis 63 771-473

[6] Lasserson DS(2016)Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review JAMA Intern Med 176 121-836

[7] Hobbs FD(2021)Incidence of Uncommon Clinical Events in USA patients with dialysis-dependent and nondialysis-dependent chronic kidney disease: analysis of electronic health records from TriNetX Nephron 145 462-254

[8] Matsushita K(2015)Data resource profile: Clinical Practice Research Datalink (CPRD) Int J Epidemiol 44 827-516

[9] van der Velde M(2006)Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med. 145 247-384

[10] Astor BC(2015)The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study BMC Nephrol 16 193-160